-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Agile Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q1 2014 to Q2 2024.
- Agile Therapeutics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2024 was 6.86M shares, a 287% increase year-over-year.
- Agile Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.16M shares, a 399% increase from 2022.
- Agile Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 432K shares, a 791% increase from 2021.
- Agile Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 48.5K shares, a 97.7% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)